The time on market factor for AE reporting volume is

Question $7$ options:

Real life exposure to drug decreases the volume of safety reports

Real life exposure to drug increases the volume of safety reports in the first couple years on the market, then plateaus and starts to decline

Real life exposure to drug increases the volume of safety reports in a linear way during postmarket lifecycle of the drug.